Search

everythinglearnresearchcommunity

for

Search:↓

Obesity is an independent risk factor for early coronary artery disease (CAD) and its severity is not affected by age.

Different medications can cause serious side effects in some people.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Certain drugs and supplements may contribute to hair loss in the frontal hairline in older women.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Older age increases positive hair alcohol test results, and chest hair is a good alternative for testing; season affects results, with higher levels in winter.

Hair loss in young adults is linked to harder arteries.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Obesity is linked to many gastrointestinal diseases and needs more research for treatment development.

Teens with PCOS have a higher risk of type 2 diabetes and need regular glucose checks.

Some teenagers with anorexia nervosa have worse cognitive abilities, especially in visual and spatial tasks, and this is more common in those with a lower body weight.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.

Metformin can start ovulation and may lower 17P response in PCOS, but six months is too short to improve hair growth or change body fat distribution.

AGA patients have lower serum vaspin levels, which might help detect the condition early.

Women with pattern hair loss may have more stress in their bodies due to a lack of NRF2, a protein. Eating healthy and losing weight could help reduce this stress and improve hair loss. NRF2 boosters might also help treat this type of hair loss.

Androgenetic alopecia is more common in male Chinese adolescents and linked to rosacea, but doesn't affect quality of life.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Higher homocysteine levels may predict hair loss severity.

Men with early hair loss and certain health factors may have a higher risk of developing reproductive issues, similar to polycystic ovary syndrome in women.

Both finasteride and metformin effectively treat PCOS by reducing hormone levels and insulin resistance.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Poor sleep is linked to a higher risk of developing and worsening urinary problems in men.

Skin and nail problems like hair loss, dry skin, and fungal infections are common in people with long-term Type 2 Diabetes and can be prevented with good blood sugar control and foot care.

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.